Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ALZN Alzamend Neuro Inc
- Stocks
- Healthcare
- NASDAQ: ALZN
Price (delayed)
$3.97
Market cap
$2.91M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$27.36
Enterprise value
-$447,903
Highlights
ALZN's EPS has soared by 84% year-on-year and by 54% since the previous quarter
ALZN's net income has soared by 66% year-on-year and by 28% since the previous quarter
ALZN's equity has surged by 181% year-on-year but it is down by 8% since the previous quarter
Key stats
What are the main financial stats of ALZN
Market
Valuations
Earnings
Shares outstanding
733,056
Market cap
$2.91M
Enterprise value
-$447,903
Price to earnings (P/E)
N/A
Price to book (P/B)
0.69
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$4.21M
Net income
-$4.23M
EBIT
-$4.21M
EBITDA
-$4.16M
Free cash flow
-$7.4M
Per share
Balance sheet
Liquidity
EPS
-$27.36
EPS diluted
-$27.36
Free cash flow per share
-$12.06
Book value per share
$5.71
Revenue per share
$0
TBVPS
$6.81
Total assets
$4.18M
Total liabilities
$725,851
Debt
$0
Equity
$3.45M
Working capital
$3.22M
Debt to equity
0
Current ratio
5.44
Quick ratio
4.63
Net debt/EBITDA
0.81
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-149.1%
Return on equity
-504.2%
Return on invested capital
N/A
Return on capital employed
-122%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ALZN stock price
How has the Alzamend Neuro stock price performed over time
Intraday
3.66%
1 week
19.58%
1 month
-34.16%
1 year
-92.39%
YTD
-61.97%
QTD
-53.46%
Financial performance
How have Alzamend Neuro's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$4.21M
Net income
-$4.23M
Gross margin
N/A
Net margin
N/A
ALZN's operating income has surged by 66% year-on-year and by 28% since the previous quarter
ALZN's net income has soared by 66% year-on-year and by 28% since the previous quarter
Price vs fundamentals
How does ALZN's price correlate with its fundamentals
Growth
What is Alzamend Neuro's growth rate over time
Valuation
What is Alzamend Neuro stock price valuation
P/E
N/A
P/B
0.69
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ALZN's EPS has soared by 84% year-on-year and by 54% since the previous quarter
ALZN's equity has surged by 181% year-on-year but it is down by 8% since the previous quarter
Efficiency
How efficient is Alzamend Neuro business performance
ALZN's ROA has soared by 69% YoY and by 49% from the previous quarter
Dividends
What is ALZN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ALZN.
Financial health
How did Alzamend Neuro financials performed over time
The company's total liabilities has shrunk by 84% YoY and by 42% QoQ
The current ratio has grown by 43% from the previous quarter
ALZN's debt is 100% smaller than its equity
ALZN's equity has surged by 181% year-on-year but it is down by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.